Amal Therapeutics

About:

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.

Website: http://www.amaltherapeutics.com

Top Investors: HTGF | High-Tech Gruenderfonds, Venture Kick, Boehringer Ingelheim Venture Fund, VI Partners, BioMedPartners

Description:

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal Therapeutics was incorporated in September 2012. Amal uses its proprietary cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology.